Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma

Clinical trial NCT03700476 · UNKNOWN

Trial details

NCT number: NCT03700476
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Neoplasms

Start date: 2018-12-21
Primary completion: 2023-02-28
Enrollment: 425

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.